Medical News

RSS

Global Healthcare REIT completes acquisition of Southern Tulsa Healthcare Center

Global Healthcare REIT, Inc. announced today that effective February 7, 2014, it completed the acquisition of its fourth facility.

13 Feb 2014

GOP states struggling with Medicaid expansion issues

Meanwhile, McClatchy News reports that higher rates of mental illness and substance abuse among the newly enrolled will be a problem because there aren't enough therapists who accept Medicaid patients. Medicaid expansion developments in New Hampshire, North Dakota, Wyoming and Virginia are also covered.

13 Feb 2014

Optum Labs announces addition of seven new charter partners to improve quality of patient care

Optum Labs, the collaborative research and innovation center founded by Optum and Mayo Clinic, today announced the addition of seven new charter partners committed to improving the quality and value of patient care. The announcement follows the recent addition of AARP as Founding Consumer Advocate Organization of the collaborative.

13 Feb 2014

Agenus closes previously announced acquisition of 4-Antibody

Agenus Inc., a biopharmaceutical company developing novel immunotherapeutics, including a portfolio of checkpoint modulators (CPMs), anti-cancer vaccines and adjuvants, today completed the previously announced acquisition of 4-Antibody AG, a private European-based biopharmaceutical company.

13 Feb 2014

Quintiles' growth in service revenues increases 7.7% in Q4 2013

Quintiles Transnational Holdings Inc. today reported its financial results for the fourth quarter ended December 31, 2013.

13 Feb 2014

FDA accepts Regado Biosciences' IND application for REG2

Regado Biosciences, Inc., a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the United States Food and Drug Administration has accepted the company's investigational new drug (IND) application for REG2. Regado previously completed a single escalating-dose Phase 1 clinical trial of REG2 and plans to conduct additional clinical testing in sub-acute venous thrombosis indications in the future.

13 Feb 2014

DataArt reports record revenue of $40 million for 2013

DataArt, a leading custom software development firm serving select industries, today announced a record revenue of $40M for 2013, a 25% annual growth, with over 90 new client wins.

13 Feb 2014

Hospi receives FDA clearance for Macy Catheter

Hospi Corporation, a privately-held medical device company focused on nurse invented products that optimize patient care, today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration for its first product, the Macy Catheter. The Macy Catheter is the only device designed and approved solely for ongoing rectal delivery of medications and liquids.

13 Feb 2014

FDA grants full approval of SYNRIBO for injection

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.

13 Feb 2014

GenVec achieves third milestone for development of treatments for hearing and balance disorderstion

GenVec, Inc. (NASDAQ: GNVC) today announced that the company has achieved the third milestone in its collaboration with Novartis for the development of treatments for hearing and balance disorders.

13 Feb 2014

Lignol Energy signs formal "MOU" for development of joint venture

Lignol Energy Corporation today announced the signing of a formal Memorandum of Understanding ("MOU") between Milio International ("Milio") and LEC's subsidiary, Territory Biofuels Limited ("TBF"), for the development of a joint venture ("JV").

13 Feb 2014

First Edition: February 13, 2014

Today's headlines include news coverage of yesterday's update from the Obama administration regarding the number of people who have enrolled in private health insurance through the health law's online marketplaces.

13 Feb 2014

Polyurethane-based adhesive based on Bayer's Baymedix A raw material now available for wound care

Bayer MaterialScience LLC announces a polyurethane-based adhesive based on its Baymedix A raw material is now available in the United States.

13 Feb 2014

Albert Einstein College professor receives AAAS 2013 Newcomb Cleveland Prize

A study describing the complete wiring diagram for the part of the nervous system that controls mating behavior in male roundworms was chosen as the most outstanding paper published in Science in the year June 2012 to May 2013.

13 Feb 2014

Viewpoints: Obama's 'cavalier approach' to health law; CBO report's job forecast isn't bad news

The Obama administration on Monday announced that it was delaying, once again, enforcement of the Affordable Care Act (ACA) "employer mandate." Yes, Republicans have done everything they can to impede implementation of this law.

13 Feb 2014

USC scientist wins AAAS Early Career Award for Public Engagement with Science

The American Association for the Advancement of Science (AAAS) has honored Mary Helen Immordino-Yang with the AAAS Early Career Award for Public Engagement with Science for her "sustained commitment and novel approach to integrating public engagement with science into her extensive research and scholarly activities and for using public interactions to inform her research."

13 Feb 2014

Congressmen to receive Edwin C. Whitehead award at Advocacy Awards Dinner

Reps. Frank Wolf (R-VA) and Chaka Fattah (D-PA) will receive the Edwin C. Whitehead Award for Medical Research Advocacy for their leadership and unwavering commitment to supporting policies that promote federal and private sector medical research and innovation.

13 Feb 2014

Novogene purchases HiSeq X Ten sequencing system from Illumina

Illumina, Inc. (NASDAQ:ILMN) today announced that Novogene (www.novogene.cn), a leading genomics service provider based in Beijing, China, purchased one HiSeq X Ten.

From Illumina, Inc. 13 Feb 2014

Researchers validate new method for calculating physical activity, sedentary behavior in obese people

Researchers at the University of South Carolina's Arnold School of Public Health have validated a new method for calculating physical activity, sedentary behavior, and the food energy requirements of Americans. The results suggest that as a nation, we spend more than 15 hours per day sleeping and sitting, and that obese men and women spend less than one minute per day in vigorous activity.

13 Feb 2014

Clot-busting tPA therapy for ischemic stroke patients can avoid lengthy, restrictive monitoring in ICU

A Johns Hopkins study of patients with ischemic stroke suggests that many of those who receive prompt hospital treatment with "clot-busting" tissue plasminogen activator (tPA) therapy can avoid lengthy, restrictive monitoring in an intensive care unit (ICU).

13 Feb 2014